Showing 1 - 2 results of 2 for search 'Diana Hernández-Sánchez', query time: 0.01s Refine Results
  1. 1
    Barriers and Facilitators of Implementation of the Non-Hospital-Based Administration of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV: Qualitative Data from the HOLA Study

    Barriers and Facilitators of Implementation of the Non-Hospital-Based Administration of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV: Qualitative Data from the HOLA... by Diana Hernández-Sánchez, Juan M. Leyva-Moral, Julian Olalla, Eugènia Negredo, on behalf of the HOLA Study Group

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)—a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol

    Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabote... by Jordi Puig, Vicenç Falcó, Cristina Miranda, Francis Ruiz, Julián Olalla, Àngel Rivero, Patricia Álvarez-Lopez, Eugenia Negredo, Diana Hernández-Sánchez, Javier Jusmet, Miguel Ángel Cuerda Palomo, Ana Belén Flores de la Cruz, José Manuel Pavón, Nadia Llavero, David Campany, Vicente Faus, Claudia Broto-Cortés, Lucía Bailón, Dámaris Aguilar, David Rovira

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: